Global Disposable Intravenous Catheter Market Size By Type (Peripheral Short, Peripheral Midline), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Disposable Intravenous (IV) Catheter Market was valued at USD 5.7 billion in 2023 and is projected to reach USD 9.6 billion by 2031, growing at a CAGR of 6.7% during the forecast period from 2023 to 2031. This growth is primarily driven by the increasing prevalence of chronic diseases, rising surgical procedures, the growing geriatric population, and the escalating demand for safe, sterile, and cost-effective medical consumables. Disposable IV catheters are vital in the administration of medications, fluids, and nutrients, making them indispensable in hospital, clinic, and emergency settings.

Drivers:

1. Rising Prevalence of Chronic Diseases:

The growing global burden of chronic conditions such as cancer, cardiovascular diseases, and diabetes is significantly increasing hospital admissions and the demand for intravenous therapies, thereby boosting market growth.

2. Increasing Surgical Procedures:

With the growing number of both elective and emergency surgeries, the use of IV catheters for drug and fluid administration continues to rise, particularly in post-operative care.

3. Growth in Geriatric Population:

Elderly patients often require frequent hospital care and IV therapies, fueling the demand for disposable IV catheters that minimize infection risk and reduce hospital-acquired infections.

4. Infection Control and Patient Safety:

The growing awareness and implementation of infection control protocols in hospitals are accelerating the adoption of single-use catheters to prevent cross-contamination.

Restraints:

1. Catheter-Associated Infections (CAIs):

Despite being sterile, improper handling or prolonged catheter use can result in bloodstream infections, which may deter usage or demand stricter protocols and more costly safety innovations.

2. Availability of Alternatives:

The increasing use of subcutaneous drug delivery methods and other alternatives may pose a minor threat to traditional IV catheter use.

Opportunity:

1. Technological Advancements and Product Innovation:

Innovation in catheter materials, needle-stick safety designs, and antimicrobial-coated products presents a significant opportunity for manufacturers to enhance value and safety.

2. Expansion in Emerging Markets:

Rising healthcare investments and infrastructure development in Asia-Pacific, Latin America, and the Middle East are creating robust demand for essential medical disposables, including IV catheters.

Market by System Type Insights:

By system type, Peripheral IV Catheters (PIVCs) accounted for the largest share of the market in 2023. These are preferred due to their ease of use, cost-effectiveness, and wide range of applications across all healthcare settings. However, Central IV Catheters (CVCs) are expected to witness steady growth owing to their increasing use in oncology and intensive care settings for long-term medication and fluid delivery.

Market by End-use Insights:

Hospitals were the dominant end-users in 2023, representing over 60% of the global market share. The high volume of in-patient care, surgical procedures, and emergency treatments in hospitals supports the large-scale use of disposable IV catheters. Ambulatory Surgical Centers (ASCs) and Home Healthcare Settings are projected to grow significantly during the forecast period due to rising outpatient care demand and home-based treatments.

Market by Regional Insights:

North America led the market in 2023 due to advanced healthcare infrastructure, high disease prevalence, and strong regulatory standards for infection control. Asia-Pacific is expected to grow at the fastest rate through 2031, driven by rising healthcare access, increasing government healthcare expenditure, and higher demand for cost-effective disposable medical devices in populous nations like China and India.

Competitive Scenario:

Key players in the Global Disposable Intravenous Catheter Market include Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical, Terumo Corporation, Nipro Corporation, Medline Industries, ICU Medical Inc., Teleflex Incorporated, Vygon Group, and Argon Medical Devices. These companies are actively focusing on product innovation, strategic acquisitions, and expansion in emerging markets.

Key Market Developments:

2023: B. Braun launched a new range of safety IV catheters with enhanced needle protection mechanisms to reduce needlestick injuries.

2024: Terumo Corporation expanded its catheter manufacturing facility in Southeast Asia to meet growing regional demand.

2025: ICU Medical Inc. introduced antimicrobial-coated IV catheters to reduce bloodstream infections, targeting critical care units globally.

Scope of Work – Global Disposable Intravenous Catheter Market

Report Metric Details

Market Size (2023) USD 5.7 Billion

Projected Market Size (2031) USD 9.6 Billion

CAGR (2023–2031) 6.7%

Market Segments By System Type (Peripheral, Central), By End-use, Region

Growth Drivers Rising chronic diseases, surgical volumes, aging population

Opportunities Product innovation, expansion in emerging markets

FAQs:

1) What is the current market size of the Global Disposable Intravenous Catheter Market?

The market was valued at USD 5.7 billion in 2023.

2) What is the major growth driver of the Global Disposable Intravenous Catheter Market?

The key growth driver is the rising prevalence of chronic diseases and associated hospital admissions.

3) Which is the largest region during the forecast period in the Global Disposable Intravenous Catheter Market?

North America is the largest region due to its advanced healthcare systems and stringent infection control protocols.

4) Which segment accounted for the largest market share in the Global Disposable Intravenous Catheter Market?

Peripheral IV Catheters accounted for the largest market share in 2023.

5) Who are the key market players in the Global Disposable Intravenous Catheter Market?

Major players include Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical, and Terumo Corporation.